A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: camrelizumab Sponsors: Fujian Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials